BRPI0606123A2 - pirrolidinas fenil-substituìdas - Google Patents
pirrolidinas fenil-substituìdasInfo
- Publication number
- BRPI0606123A2 BRPI0606123A2 BRPI0606123-0A BRPI0606123A BRPI0606123A2 BR PI0606123 A2 BRPI0606123 A2 BR PI0606123A2 BR PI0606123 A BRPI0606123 A BR PI0606123A BR PI0606123 A2 BRPI0606123 A2 BR PI0606123A2
- Authority
- BR
- Brazil
- Prior art keywords
- compounds
- phenyl
- methods
- substituted
- substituted pyrrolidines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64802705P | 2005-01-28 | 2005-01-28 | |
| PCT/US2006/003217 WO2006081554A2 (en) | 2005-01-28 | 2006-01-30 | Phenyl-substituted pyrrolidones |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0606123A2 true BRPI0606123A2 (pt) | 2009-06-02 |
Family
ID=36741146
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0606123-0A BRPI0606123A2 (pt) | 2005-01-28 | 2006-01-30 | pirrolidinas fenil-substituìdas |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20080287516A1 (enExample) |
| EP (1) | EP1841425A4 (enExample) |
| JP (1) | JP2008528624A (enExample) |
| KR (2) | KR100896889B1 (enExample) |
| CN (1) | CN101115481A (enExample) |
| AU (1) | AU2006209245A1 (enExample) |
| BR (1) | BRPI0606123A2 (enExample) |
| CA (1) | CA2594915A1 (enExample) |
| MX (1) | MX2007009137A (enExample) |
| RU (1) | RU2371433C2 (enExample) |
| WO (1) | WO2006081554A2 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003078448A1 (en) | 2002-03-13 | 2003-09-25 | Signum Biosciences, Inc. | Modulation of protein methylation and phosphoprotein phosphate |
| MX2007008974A (es) * | 2005-01-28 | 2007-09-18 | Irm Llc | Sintesis de aril-pirrolidonas. |
| US7923041B2 (en) | 2005-02-03 | 2011-04-12 | Signum Biosciences, Inc. | Compositions and methods for enhancing cognitive function |
| WO2006084033A1 (en) | 2005-02-03 | 2006-08-10 | Signum Biosciences, Inc. | Compositions and methods for enhancing cognitive function |
| JP5164510B2 (ja) * | 2006-10-06 | 2013-03-21 | 日本曹達株式会社 | 含窒素複素環化合物および有害生物防除剤 |
| US8455513B2 (en) | 2007-01-10 | 2013-06-04 | Aerie Pharmaceuticals, Inc. | 6-aminoisoquinoline compounds |
| CN102014897B (zh) | 2008-04-21 | 2015-08-05 | 西格纳姆生物科学公司 | 化合物、组合物和其制备方法 |
| US8450344B2 (en) | 2008-07-25 | 2013-05-28 | Aerie Pharmaceuticals, Inc. | Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |
| CN101747253B (zh) * | 2008-12-02 | 2013-01-16 | 中国人民解放军军事医学科学院毒物药物研究所 | 三取代的手性内酰胺类衍生物及其制备方法和用途 |
| WO2010126626A2 (en) | 2009-05-01 | 2010-11-04 | Aerie Pharmaceuticals, Inc. | Dual mechanism inhibitors for the treatment of disease |
| GB2497476B (en) * | 2010-09-06 | 2018-01-10 | Guangzhou Inst Biomed & Health | Amide Compounds |
| CN101979378B (zh) * | 2010-10-13 | 2012-06-27 | 中国科学院上海有机化学研究所 | 一种手性γ-内酰胺化合物的合成方法 |
| ES2776199T3 (es) | 2013-03-15 | 2020-07-29 | Aerie Pharmaceuticals Inc | Conjugados de compuestos de isoquinolina y prostaglandinas |
| WO2018045091A1 (en) | 2016-08-31 | 2018-03-08 | Aerie Pharmaceuticals, Inc. | Ophthalmic compositions |
| CA3057872A1 (en) * | 2017-03-31 | 2018-10-04 | Aerie Pharmaceuticals, Inc. | Aryl cyclopropyl-amino-isoquinolinyl amide compounds |
| WO2019046467A1 (en) * | 2017-08-29 | 2019-03-07 | Rutgers, The State University Of New Jersey | INDAZOLES THERAPEUTIC |
| AU2019337703B2 (en) | 2018-09-14 | 2023-02-02 | Aerie Pharmaceuticals, Inc. | Aryl cyclopropyl-amino-isoquinolinyl amide compounds |
| AU2019387370A1 (en) | 2018-11-30 | 2021-06-10 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU797219A1 (ru) * | 1979-05-08 | 1995-07-25 | Ленинградский государственный педагогический институт им.А.И.Герцена | N-карбамоилметил-4-фенил-2-пирролидон, обладающий гипотензивной активностью |
| TW448172B (en) * | 1996-03-08 | 2001-08-01 | Pharmacia & Upjohn Co Llc | Novel hydroxamic acid derivatives useful for the treatment of diseases related to connective tissue degradation |
| AU2003285952A1 (en) * | 2002-10-21 | 2004-05-13 | Irm Llc | Pyrrolidones with anti-hiv activity |
-
2006
- 2006-01-30 KR KR1020077017487A patent/KR100896889B1/ko not_active Expired - Fee Related
- 2006-01-30 AU AU2006209245A patent/AU2006209245A1/en not_active Abandoned
- 2006-01-30 JP JP2007553324A patent/JP2008528624A/ja active Pending
- 2006-01-30 KR KR1020097004694A patent/KR20090028846A/ko not_active Ceased
- 2006-01-30 US US11/814,480 patent/US20080287516A1/en not_active Abandoned
- 2006-01-30 BR BRPI0606123-0A patent/BRPI0606123A2/pt not_active IP Right Cessation
- 2006-01-30 RU RU2007132259/04A patent/RU2371433C2/ru not_active IP Right Cessation
- 2006-01-30 WO PCT/US2006/003217 patent/WO2006081554A2/en not_active Ceased
- 2006-01-30 MX MX2007009137A patent/MX2007009137A/es not_active Application Discontinuation
- 2006-01-30 CA CA002594915A patent/CA2594915A1/en not_active Abandoned
- 2006-01-30 CN CNA2006800033348A patent/CN101115481A/zh active Pending
- 2006-01-30 EP EP06734052A patent/EP1841425A4/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| RU2007132259A (ru) | 2009-03-10 |
| MX2007009137A (es) | 2007-09-12 |
| EP1841425A2 (en) | 2007-10-10 |
| AU2006209245A1 (en) | 2006-08-03 |
| RU2371433C2 (ru) | 2009-10-27 |
| JP2008528624A (ja) | 2008-07-31 |
| KR20070103404A (ko) | 2007-10-23 |
| WO2006081554A3 (en) | 2006-12-14 |
| EP1841425A4 (en) | 2009-02-18 |
| CN101115481A (zh) | 2008-01-30 |
| KR20090028846A (ko) | 2009-03-19 |
| US20080287516A1 (en) | 2008-11-20 |
| KR100896889B1 (ko) | 2009-05-14 |
| WO2006081554A2 (en) | 2006-08-03 |
| CA2594915A1 (en) | 2006-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201000777A1 (ru) | Ингибиторы репликации вируса иммунодефицита человека | |
| EP2494059A4 (en) | USE OF METHYLSULFONYLMETHANE (MSM) TO MODULATE MICROBIAL ACTIVITY | |
| TN2010000137A1 (en) | Spiropyrrolidines and their use against hcv and hiv infection | |
| WO2008127364A3 (en) | Antiviral compounds and use thereof | |
| EA201101620A1 (ru) | Ингибиторы репликации вируса иммунодефицита человека | |
| BRPI0717266A2 (pt) | Derivados de oxindol | |
| TW200738728A (en) | HIV integrase inhibitors | |
| MX2008012576A (es) | Pirimidinas 5-amido sustituidas inhibidoras del virus de inmunodeficiencia humana. | |
| MX2010009995A (es) | Heterociclos puenteados como inhibidores de la integrasa del virus de inmunodeficiencia humana. | |
| CL2007003645A1 (es) | Compuestos parasiticidas derivados de aril-pirazoles sustituidos; compuestos intermediarios; composicion farmaceutica; y uso para tratar una infeccion parasitaria. | |
| MA38182A1 (fr) | Compositions pharmaceutiques a action prolongée pur une utilisation dans le traitement ou la prévention d'infections par le virus de l’immunodéficience humaine (vih) | |
| WO2008073138A3 (en) | Terephthalamate compounds and compositions, and their use as hiv integrase inhibitors | |
| WO2006081554A3 (en) | Phenyl-substituted pyrrolidones | |
| CL2003001087A1 (es) | Compuestos derivados de amidas de 4-alquenil piperidina de indol, azaindol y relacionadas con heterociclicos, composicion farmaceutica, util para tratar una infeccion del vih. | |
| BRPI0509140A (pt) | processos para o tratamento de infecção por hiv | |
| DK2101792T3 (da) | Anvendelse af carrageenan til behandling af rhinovirus-infektioner | |
| BRPI1012666B8 (pt) | cocristal de etravirina e nicotinamida, composição farmacêutica, combinação compreendendo o mesmo, seu processo para a preparação e uso | |
| EA201101397A1 (ru) | Ингибиторы репликации вируса иммунодефицита человека | |
| WO2007059125A3 (en) | Hiv integrase inhibitors | |
| EP2182937A4 (en) | ANTIVIRAL COMPOSITION | |
| BRPI0605926A2 (pt) | ciclopentanos substituìdos ou ciclopentanonas como agentes terapêuticos | |
| TW200738700A (en) | HIV integrase inhibitors | |
| WO2007098247A3 (en) | Substituted taraxastanes useful for treating viral infections | |
| ATE475424T1 (de) | Cellulosesulfat zur behandlung von rhinovirus- infektionen | |
| TW200716571A (en) | Heterocyclic reverse transcriptase inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A E 6A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2161 DE 05/06/2012. |